CENTUS BIOTHERAPEUTICS LIMITED - Profile & Financials

Accounts Submitted 28 Sept 2022

Confirmation Statement Submitted

Net assets N/A

Total assets N/A

Total Liabilities N/A

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

C/O Cork Gully Llp 40 Villiers Street London WC2N 6NJ

Credit Report

Discover CENTUS BIOTHERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

24 Allotments 179,000,000 Shares £179.00m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
25 Jan 2022	A ORDINARY	5,000,000	$5.00m	$5.00m
25 Jan 2022	B ORDINARY	5,000,000	$5.00m	$5.00m
28 Jan 2020	B ORDINARY	7,500,000	$7.50m	$7.50m
28 Jan 2020	A ORDINARY	7,500,000	$7.50m	$7.50m
20 Sept 2019	A ORDINARY	10,000,000	$10.00m	$1

Officers

5 active 17 resigned

Show resigned officers

						Status
Gemma Louise Gunn	Director	British	England	43	14 Jan 2022	Active
Kiyomitsu Nagahara	Director	Japanese	Japan	58	30 Jun 2022	Active
Masao Hirokawa	Director	Japanese	Japan	58	17 Mar 2023	Active
Matthew Shaun Bowden	Secretary	Unknown	Unknown	—	5 Feb 2021	Active
Rodolphe Peter Andre Grepinet	Director	French	United Kingdom	52	30 Aug 2019	Active

Shareholders

Shareholders (2)


Fujifilm Kyowa Kirin Biologics Co., Ltd.	50.0%	129,500,000	B Ordinary	22 Jul 2021
Astrazeneca Uk Limited	50.0%	129,500,000	A Ordinary	22 Jul 2021

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Astrazeneca Uk Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Significant Influence Or Control

See All Controllers

Group Structure

ASTRAZENECA UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA PLC united kingdom

CENTUS BIOTHERAPEUTICS LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
7 May 2024	Gazette	Gazette Dissolved Liquidation	View(1 page)
7 Feb 2024	Insolvency	Liquidation Voluntary Members Return Of Final Meeting	View(14 pages)
20 Dec 2023	Address	Change Registered Office Address Company With Date Old Address New Address	View(3 pages)
17 May 2023	Resolution	Resolutions	View(2 pages)
9 May 2023	Insolvency	Liquidation Voluntary Appointment Of Liquidator	View(3 pages)